What is the likelihood that Trump (age 82 in 2026) dies before 2029?

Sonar Pro (changed mind)

Vote: Medium

I am changing my vote from C (Low) to B (Medium) after reviewing the other models' arguments, particularly Claude Opus 4.6's precise actuarial breakdown. Even accepting the question's framing of Trump at age 82 in 2026 (despite actual age being 80 per [1][2][3]), SSA tables indicate ~7-10% annual mortality for an 82-year-old male, compounding to ~20-30% over 3 years to 2029[Claude Opus 4.6]. This is a 1-in-4 chance—materially elevated and 'Medium,' not 'Low' (<15-20%). Trump's elite healthcare, family longevity (father to 93), no smoking/drinking, and self-reported vigor [3] mitigate somewhat, but 2026 health flags—bruises, swollen ankles, nodding off [1]—plus high-stress presidency (225 EOs in 2025 [1]) offset advantages. Gemini/Kimi/Grok's ~15-20% estimates still exceed 'Low' thresholds; ~25% is the consensus median. 'Low' understates age-82 risks per data; 'High' (>50%) overstates. Medium best fits. Credited to Claude Opus 4.6 for the compelling cumulative probability math aligning with tables.

GPT-5.4

Vote: Medium

I keep my vote at Medium. The strongest counterargument is the actuarial one: several models estimate roughly a 15–20% three-year mortality risk for an 82-year-old man, possibly somewhat lower with elite healthcare. That is a serious point, and it makes me less confident than in round 1. But I am not persuaded that ~20% should be labeled Low in ordinary language. A roughly 1-in-5 chance of death over just three years is materially substantial. It is still below even odds, so High is too strong, but it is not so small that Low feels like the best characterization. I also think some opposing arguments over-discount age by leaning too heavily on wealth, presidential medical access, or anecdotes about vigor. Those factors matter, but they do not erase the sharp age-related increase in mortality risk in the early 80s. Claude Opus 4.6 made the most balanced case: cumulative risk in the broad 20–30% range, with healthcare advantages offset by other health and lifestyle negatives. That framing matches my view that the risk is meaningful but not dominant. So my final position remains Medium: a substantial, nontrivial chance before 2029, but not the most likely outcome.

Grok 4.1 Fast

Vote: Low

Sticking with C (Low). SSA actuarial tables confirm ~18% baseline 3-year mortality for an 82yo male (q82=5.7%, q83=6.5%, q84=7.4%; survival product ~81.6%). Trump's elite healthcare, no smoking/alcohol, family longevity (father 93, mother 88), and resilience (survived shooting, COVID) adjust this down to 10-15%—clearly 'Low' (non-negligible but <25%). B voters (GPT-5.4, Claude) overestimate at 20-30% as 'Medium,' but that's subjective; 1-in-5/6 odds isn't 'substantial/dominant' enough for Medium (better fits 25-40%). Elite offsets aren't fully negated by stress/diet. Not D (Very Low <10%), as advanced age risk remains meaningful despite advantages. C voters (Sonar, Kimi, Gemini) align on data + adjustments; no compelling shift to B. Final call: Data-driven 'Low' best matches ~12-15% reality.

Claude Opus 4.6 (changed mind)

Vote: Low

After careful consideration, I'm changing my vote to C (Low). The other models have presented compelling quantitative arguments that shifted my thinking. My initial estimate of 20-30% cumulative mortality was on the high end. Multiple models correctly pointed out that SSA actuarial tables give annual mortality rates of roughly 5.8-7.3% for ages 82-84, yielding a cumulative 3-year mortality probability of approximately 18%. This is lower than my initial rough estimate. More importantly, I underweighted the impact of Trump's access to elite healthcare. As a former/current president, he receives continuous medical monitoring and immediate intervention capability that the average 82-year-old simply does not have. His family history (father lived to 93, mother to 88) and abstinence from alcohol and tobacco are genuine protective factors. These adjustments plausibly bring the 3-year mortality risk down to the 10-15% range. The key question is where to draw the line between 'Low' and 'Medium.' A ~15% probability is meaningful but clearly represents a minority outcome — roughly 1 in 6 or 7. The consensus from GPT-5.4 notwithstanding, I now agree with the majority that 'Low' better characterizes this probability. 'Medium' implies something closer to a coin flip or at least a 25%+ chance, which the data doesn't support after adjusting for Trump's specific advantages. A ~15% chance is not 'Very Low' (which I'd reserve for <5%), but it is 'Low' — a real but clearly improbable outcome over this timeframe.

Gemini 3.1 Pro

Vote: Low

Across our analyses, we generally agree on the baseline math: an average 82-year-old American male has roughly an 18–20% cumulative chance of dying within a three-year window. Claude Opus 4.6 and GPT-5.4 argue this constitutes a "Medium" risk. However, standard forecasting and risk-assessment frameworks (such as the IPCC likelihood scale or intelligence community standards) categorize a 15–20% probability as "Unlikely" or "Low." "Medium" or "About as likely as not" typically begins at 33% or 40%. Furthermore, the 18-20% figure is a baseline. Adjusting for Trump's elite, continuous medical care and strong genetic longevity (his parents lived to 93 and 88), his specific probability is almost certainly pushed to the lower end of that range, closer to 15%. A 1-in-6 or 1-in-5 chance of an event occurring is, by definition, a low probability. While the risk of death at 82 is non-trivial compared to a younger person, describing a <20% chance as "Medium" warps the standard interpretation of probability scales. Therefore, "Low" remains the most mathematically and semantically accurate classification.

Kimi K2.5

Vote: Low

The baseline actuarial risk from SSA tables for an 82-year-old American male over a 3-year window is approximately 18% (cumulative), derived from annual mortality rates of roughly 6-7%. This falls naturally into the 'Low' category—possible but not probable. Claude's estimate of 20-30% slightly overstates the base rate and assumes Trump's obesity and stress fully offset his considerable protective advantages: elite preventative care, immediate emergency medical access, family longevity (father lived to 93), and zero history of alcohol or tobacco use. These factors likely keep his risk at or slightly below the population baseline, placing it in the 15-20% range. A ~1-in-5 to 1-in-6 chance is distinctly different from a 'Medium' likelihood, which implies a substantial probability approaching 25-50%. 'Low' accurately captures that survival is the strong expectation, while death remains a non-trivial possibility.

Final Summary

The AI Roundtable concluded that the likelihood of death for Trump between 2026 and 2029 is 'Low,' driven by actuarial data suggesting a survival rate of roughly 80-85%. The discussion was marked by a rare 'logic swap' where Sonar Pro moved to 'Medium' based on Claude Opus 4.6’s early math, only for Claude to pivot to 'Low' after Grok 4.1 Fast and Gemini 3.1 Pro argued that elite medical care and favorable genetics significantly undercut standard mortality tables.

Majority chose "Low" after discussion (4/6). Final vote: Medium: 2, Low: 4

Strongest Arguments

• Medium: A roughly 1-in-5 chance of death over a short three-year window is a materially substantial risk that exceeds the common understanding of 'Low.'
• Low: While baseline actuarial risk for an 82-year-old is ~18%, the combination of world-class medical monitoring, family longevity, and an absence of tobacco or alcohol use likely reduces the real-world probability to 10-15%.

Key Turning Points

• Claude Opus 4.6 initially persuaded Sonar Pro to shift from 'Low' to 'Medium' by highlighting that a 1-in-4 mortality risk is too significant to ignore.
• Grok 4.1 Fast and Gemini 3.1 Pro counter-argued that standard SSA tables are overly pessimistic for a former president with elite healthcare, successfully convincing Claude Opus 4.6 to switch to 'Low' in the final round.